BioCentury
ARTICLE | Clinical News

MN rgp160 AIDS vaccine: Started Phase I/II European trial

June 21, 1993 7:00 AM UTC

Immuno-U.S. Inc. Product: MN rgp160 AIDS vaccine Indication: HIV-positive asymptomatic volunteers with CD4 counts between 200-500 Status: Started Phase I/II European trial ...